Introduction
Japanese Society for Dialysis Therapy (JSDT) has been conducting an annual survey on the current status of regular dialysis treatment in Japan (JSDT Renal Data Registry (JRDR)) at the end of each year since 1968. Since 1983, survey items relating to all dialysis patients treated in dialysis facilities that participated in the surveys have been included and the obtained data have been registered in an electronic database [1] . In the 2009 survey, JSDT started the peritoneal dialysis (PD) registry survey of patients who underwent PD, in cooperation with Japanese Society for Peritoneal Dialysis (JSPD) [2] . The targets of the PD registry survey include facilities that offer PD alone, which were not targeted in the conventional surveys conducted at the end of each year. The results of the PD registry survey have been reported annually in the sections "Current status of PD treatment" and "Items associated with PD" of the "An Overview of Regular Dialysis Treatment in Japan" compiled by Committee of Renal Data Registry (CRDR) in JSDT. In 2012, the results of the PD registry survey were separated from the above overview and independently summarized in the PD registry survey report as an academic paper. The current manuscript is the second publication of "Peritoneal dialysis (PD) registry with 2014 survey report. J Jpn Soc Dial Ther 49(1):35-40, 2016," written in Japanese.
Here, the data obtained from the 2014 PD registry survey are summarized in the following six topics:
I. Current status of PD patients II. Urine output and volume of water removed by PD III. Dialysate/plasma creatinine (D/P Cr) ratio in a peritoneal equilibration test (PET) IV. Kt/V for residual renal function (residual renal Kt/V) and Kt/V for PD (PD Kt/V) V. Peritonitis and catheter exit-site infections VI. Encapsulating peritoneal sclerosis (EPS)
Outline of the PD registry in 2014
Survey methods This survey was conducted by sending questionnaires to individual dialysis facilities. A total of 4367 facilities participating in this survey were either member facilities of JSDT, nonmember facilities offering regular hemodialysis (HD), or nonmember facilities offering PD but not HD, as of December 31, 2014. The number of participating facilities increased by 42 (1.0%) from the previous year (4325 facilities) [3] . Among the 4367 facilities, 986 treated PD patients.
Universal serial bus (USB) memory devices that stored electronic spreadsheets in Microsoft Excel® or paper questionnaires were sent to and collected from the individual dialysis facilities, mainly by postal mail; for some facilities, the questionnaires were sent and collected by fax. In the 2014 survey, two sets of questionnaires were used. One was for the facility survey, which included items on individual dialysis facilities, such as the numbers of patients and staff members. The other was for the patient survey, which included items on individual dialysis patients, such as their demographical background, treatment conditions, and outcomes of treatment. The deadline for acceptance of responses was the end of January 2015. The acceptance of responses submitted after this deadline, including those of the additional surveys, ended on August 7, 2015.
Before 2014, the results from JRDR had been reported in the following three types of report. First, quick analyses of the data obtained by April in the following year were reported at the annual meeting of the JSDT held in June and compiled in "The Atlas, Overview of Regular Dialysis Treatment in Japan," Second, the responses to the survey had been continuously collected until September, and the obtained data were screened to determine the definite survey results, which were published in the "An Overview of Regular Dialysis Treatment in Japan, the CD-ROM Report." Third, the tabulated results based on the definite values in the CD-ROM Report were published as an annual dialysis data report in the Journal of Japanese Society for Dialysis Therapy. Therefore, the values in the atlas were different from the definite values in the CD-ROM. The quick estimations were prepared only for the atlas in the annual meeting of JSDT. However, the values in the atlas had been occasionally cited as if they were officially approved values because they were expressed by attractive graphs. To avoid these mal-citations, we decided to publish all the official reports from the 2014 survey based on the definite database.
For the CD-ROM Report, the number of facilities that responded to the facility survey was 4330 (99.2%) and the number of those that responded to both the facility and patient surveys was 4191 (96.0%) [4] . Moreover, the number of facilities that completed the questionnaires using the electronic medium was 3764 (86.9%), which was higher than that in the 2013 survey (3698 facilities, 86.6%). This increase contributed to the accurate and simplified analysis of survey data.
Survey items
The 2014 survey included the following survey items. For the items included in the previous surveys, refer to the membersonly pages of the JSDT website (http://member.jsdt.or.jp/ member/contents/data/research_list_2000-2015.pdf).
Facility survey items
Name of facility, contact numbers (telephone and fax), name of representative (doctor), and name of respondent Year and month when the facility started offering dialysis treatment 
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These data were obtained by the patient survey The following were added to the basic survey items and were surveyed using both paper and electronic media.
Dialysis modality, current status of combined use of PD, and HD or HDF History of PD Number of renal transplantations These data were obtained from the PD-only patients in the patient survey These data were obtained from the PD-only patients in the patient survey Values in parentheses under each figure represent the percentage relative to the total in each row APD automated peritoneal dialysis Table 6 Urine output, by PD vintage PD vintage <100 mL/day 100-<400 mL/day 400-<800 mL/day 800-1200 mL/day 1200-<1600 mL/day 
USB-only survey items
Details of PD were surveyed as USB-only survey items separately from the abovementioned questionnaires for the facility and patient surveys. The following are the USB-only survey items associated with PD.
PD vintage (months)
Number of months when PD was performed in 2014 Performance or nonperformance of PET These data were obtained from the PD-only patients in the patient survey Results and discussion
Current status of PD patients Number of patients
According to the facility survey, the number of PD patients was 9255 at the end of 2014, a decrease of 137 from the previous year. The percentage of PD patients among the entire dialysis patient population was 2.9%, a decrease of 0.1% from the previous year. The number of patients who underwent a nonPD modality but despite having a PD catheter, most of whom are considered to have undergone only peritoneal lavage, was 278 and it was a decrease of 14 from the previous year. The number of new patients who were started PD in 2014 but switched to another method in the same year was 193, an increase of 19 from the previous year. The number of patients on the combination therapy of PD and HD or HDF was 1913, a decrease of 7 from the previous year (Table 1) .
Current status of the combination therapy of PD + HD(F) with respect to PD vintage
To the questions regarding PD vintage and current status of PD + HD(F), 5678 patients responded. The percentage of patients who underwent PD + HD(F) increased with PD vintage (<1 year, 3.3%; 1-<2 years, 10.1%; 2-<4 years, 16.3%; 4-<6 years, 26.9%; 6-<8 years, 40.9%; 8-<10 years, 53.5%; and ≥10 years, 58.7%). Regarding the frequency of HD(F), the majority of the PD patients underwent HD(F) once a week (nearly 82.8%) ( Table 2 ).
Changing maneuver of PD fluids
To the questions regarding the method of PD solution exchange, 4417 of the PD-only patients responded. The number of PD patients who performed completely manual PD fluid exchanges was 1422 (32.2%). The number of PD patients who used a double-bag system with ultraviolet light irradiation was 2322 (52.6%), and the number of those who used the same system but with a sterile connecting device was 607 (13.7%) ( Table 3) .
Use or nonuse of APD machine with respect to PD vintage
Among the PD-only patients, 4446 responded to the questions regarding their PD vintage and use or nonuse of an APD machine. The percentage of PD-only patients who used an APD machine was 45.2%. The percentages of PD-only patients who used an APD machine were ≥40% for PD vintages of <6 years (<1 year, 47.2%; 1-<2 years, 50.0%; 2-<4 years, 44.2%; and 4-<6 years, 44.4%). However, the percentage of PD-only patients who used an APD machine decreased to around 30% for PD vintages of ≥6 years (≥10 years, 31.7%) ( Table 4) .
Number of hours of PD session per day with respect to PD vintage
Among the PD-only patients, 4244 responded to the questions regarding their PD vintage and PD treatment time per day. The percentage of patients who underwent PD for the whole day (24 h) was 55.5%. The percentages of patients who underwent PD for the whole day tended to increase with PD vintage (<1 year, 42.8%; 8-<10 years, 79.6%; and ≥10 years, 76.0%) ( Table 5) . Urine output and ultrafiltration volume by PD Urine output by PD vintage
To the questions regarding urine output and PD vintage, 3702 of the PD-only patients responded. The mean urine output of the PD patients was 748.9 mL/day. The urine output tended to decrease with increasing PD vintage (<1 year, 970.0 mL/day and ≥10 years, 239.5 mL/day) ( Table 6 ).
Ultrafiltration volume by PD by PD vintage
To the questions regarding the ultrafiltration volume by PD and PD vintage, 3914 of the PD-only patients responded. The mean ultrafiltration volume by PD was 615.8 mL/day. The mean ultrafiltration volume by PD tended to increase with PD vintage (<1 year, 450.3 mL/ day and ≥10 years, 838.5 mL/day) ( Table 7) .
Peritoneal equilibration test (PET) History of PET
To the questions regarding the history of PET, 4390 of the PD-only patients responded. Among these patients, 1885 (42.9%) underwent a standard PET and 992 (22.6%) underwent a fast PET; that is, a total of 2877 (65.5%) underwent PET (Table 8) .
PET D/P Cr ratio and type of PD fluid
To the questions regarding the type of PD fluid, 4508 of the PD-only patients responded. Among these patients, 2782 (61.7%) used 1.5 or 2.5% dextrose and only 10 (0.2%) used 4.25% dextrose. The number of patients who used icodextrin was 1719 (38.1%). The percentage of patients who used icodextrin increased with PET D/P Cr ratio (<0.5, 26.0%; 0.5-<0.65, 30.5%; 0.65-<0.81, 45.5%; and ≥0.81, 56.7%) ( Table 9 ).
Residual renal Kt/V and PD Kt/V Residual renal Kt/V by PD vintage
To the questions regarding the residual renal Kt/V and PD vintage, 1764 of the PD-only patients responded.
The mean residual renal Kt/V was 0.66. The mean residual renal Kt/V decreased with increasing PD vintage of <8. For patients with PD vintage of ≥8, the residual renal Kt/V was considered to be varied significantly among patients (Table 10) .
PD Kt/V by PD vintage
To the questions regarding PD Kt/V and PD vintage, 1937 of the PD-only patients responded. The mean PD Kt/V was 1.31. The mean PD Kt/V tended to increase with increasing PD vintage (<1 year, 1.10 and ≥10 years, 1.51) (Table 11 ).
Peritonitis and catheter exit-site infections
Peritonitis is defined as a white blood cell count of ≥100/μL (neutrophil, ≥50%) in waste PD fluid. A catheter exit-site infection is defined by the presence of purulent drainage from the exit site. The rates of peritonitis and catheter exit-site infections were calculated in the PD-only patients using the following formulae.
Patient's peritonitis rate
The patient's peritonitis rate per patient-year was calculated as follows, The patient's peritonitis rate per patient-year ¼ À Peritonitis episodes in 2014 in all subjects Ä Total months on PD in 2014 in all subjectsÞ Â 12 According to the International Society for Peritoneal Dialysis (ISPD) guidelines (Peritoneal Dialysis-Related Infection Recommendations: 2010 Update) [5] , "the center's peritonitis rate should be no more than 1 episode every 18 months (0.67 per patient-year)."
To the questions regarding peritonitis, 4301 of the PD-only patients responded. The mean peritonitis rate was 0.21 per patient-year (1 episode every 57.1 patientmonths). This was much lower than the recommendation in the ISPD guidelines. The number of patients who did not develop peritonitis in 2014 was 3758 (87.4%). The number of patients with a peritonitis rate These data were obtained from the PD-only patients in the patient survey The center's ESI rate per patient-year = (ESI episodes in 2014 in all patients in the center ÷ Total months on PD in 2014 in all patients in the center) × 12 of 1.0-<2.0 was 400 (9.3%) and that with a peritonitis rate of ≥2.0 was 143 (3.3%) (Table 12 ).
Center's peritonitis rate
The center's peritonitis rate was calculated as follows,
The center's peritonitis rate per patient-year ¼ À Peritonitis episodes in 2014 in all patients in the center Ä Total months on PD in 2014 in all patients in the centerÞ Â 12
On the basis of the valid responses obtained from 227 centers, the mean center's peritonitis rate was 0.21 per patient-year (1 episode each 57.1 patientmonths) (Table 13 ).
Patient's catheter exit-site infection (ESI) rates
The patient's ESI rate was calculated as follows, To the questions regarding ESI, 4289 of the PD-only patients responded. The mean patient's ESI rate in the PD-only dialysis patients was 0.40 per patient-year (1 episode every 30.0 patient-months). The number of patients who did not develop ESI in 2014 was 3465 (80.8%). The number of patients with ESI rate of 1.0-<2.0 was 495 (11.5%) and that with ESI rate of ≥2.0 was 329 (7.7%) (Table 14) .
Center's ESI rate
The center's ESI rate was calculated as follows. (Table 15 ).
Encapsulating peritoneal sclerosis (EPS) History of EPS in the patients with PD history
The history of EPS and the treatments for EPS, surgical treatment and/or steroids, were surveyed on the patients on PD and the patients with past PD history currently on another dialysis modality. Among the 12,865 patients who responded to the questions regarding their history of EPS, 676 (5.3%) had a history of EPS. Among these 676 patients, 541 (80.0%) had received surgical treatments (Table 16 ).
History of EPS by PD vintage
Responses to the questions regarding PD vintage and EPS history were obtained from 4917 patients. The percentages of patients with a history of EPS who had undergone PD for <6 years were low (<1 year, 0.4%; 1-<2 years, 0.7%; 2-<4 years, 0.5%; and 4-<6 years, 0.3%). However, the percentages of such patients who had undergone PD for a longer duration increased to around 1% (6-<8 years, 1.6%; 8-<10 years, 1.1%; and ≥10 years, 0.9%) (Table 17) . These data were obtained from the patients on PD and the patients with past PD history currently on another dialysis modality EPS encapsulating peritoneal sclerosis 
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These data were obtained from the patients on PD and the patients with past PD history currently on another dialysis modality
Conclusions
The number of PD patients has been stable around 9000~10,000 in these 10 years, and the penetration rate of PD among all dialysis patients was just 2.9%, which is one of the lowest numbers in the world. There were several unique points in the current status of PD therapy in Japan compared with other many countries. One of them was the combination therapy of PD and other dialysis modality and 21% of the PD patients were on the combination therapy. The second is lower PD dialysis dose as the mean PD Kt/V was 1.31, and it was supposed to be smaller than that from the world reports. The third is the lower risk of PD-related infections as the patient's peritonitis rate was 0.21 per patient-year and it was smaller than that of ISPD guideline. The final is about EPS. The percentage of the patients with the history of EPS among the patients with current and past PD treatment was 5.3%, and 80% of them had received the surgical treatment. The PD registry in Japan has clarified unique points in the current status of PD therapy in Japan and the differences from the trends in the other countries in the world. Based on the further analysis of the PD registry data, we would like to improve the quality of PD therapy in Japan and send messages about the merits of our therapeutic policy to the world. 
